title: Long-term efficiency of intravenously administered immunoglobulin in anti-Yo syndrome with paraneoplastic cerebellar degeneration.
authors.forename: J
authors.initials: J
authors.lastname: Schessl
authors.forename: M
authors.initials: M
authors.lastname: Schuberth
authors.forename: P
authors.initials: P
authors.lastname: Reilich
authors.forename: P
authors.initials: P
authors.lastname: Schneiderat
authors.forename: N
authors.initials: N
authors.lastname: Strigl-Pill
authors.forename: M C
authors.initials: MC
authors.lastname: Walter
authors.forename: B
authors.initials: B
authors.lastname: Schlotter-Weigel
authors.forename: B
authors.initials: B
authors.lastname: Schoser
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects; D016190:Carboplatin / Q000009:adverse effects; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D010051:Ovarian Neoplasms / Q000150:complications / Q000188:drug therapy; D017239:Paclitaxel / Q000009:adverse effects; D020362:Paraneoplastic Cerebellar Degeneration / Q000188:drug therapy*; D011115:Polyneuropathies / Q000139:chemically induced
chemical_list: D000970:Antineoplastic Agents; D016756:Immunoglobulins, Intravenous; D016190:Carboplatin; D017239:Paclitaxel